Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Common Equity: 2010-2024

Historic Common Equity for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to -$13.2 million.

  • Cryo Cell International's Common Equity fell 5515.71% to -$14.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$14.8 million, marking a year-over-year decrease of 5515.71%. This contributed to the annual value of -$13.2 million for FY2024, which is 1980.54% down from last year.
  • Per Cryo Cell International's latest filing, its Common Equity stood at -$13.2 million for FY2024, which was down 1980.54% from -$11.0 million recorded in FY2023.
  • In the past 5 years, Cryo Cell International's Common Equity registered a high of $4.2 million during FY2021, and its lowest value of -$13.2 million during FY2024.
  • Its 5-year average for Common Equity is -$4.9 million, with a median of -$2.7 million in 2020.
  • As far as peak fluctuations go, Cryo Cell International's Common Equity surged by 25700.2% in 2021, and later crashed by 62369.07% in 2023.
  • Over the past 5 years, Cryo Cell International's Common Equity (Annual) stood at -$2.7 million in 2020, then skyrocketed by 257.0% to $4.2 million in 2021, then tumbled by 136.43% to -$1.5 million in 2022, then tumbled by 623.69% to -$11.0 million in 2023, then dropped by 19.81% to -$13.2 million in 2024.
  • Its Common Equity stands at -$13.2 million for FY2024, versus -$11.0 million for FY2023 and -$1.5 million for FY2022.